Michael He, Ph.D., BPharm (Hons) (@themichaelhe) header
Michael He, Ph.D., BPharm (Hons) (@themichaelhe) profile picture

Study #lymphoma, #epigenetics, #protac, #immune @PMcancercentre🇨🇦 | Founder @UHNPostdocs | Delegate @OICRRisingStars | Alum @PeterMacCC🇦🇺

Toronto, Ontario
Joined May 2021
Photo by Michael He, Ph.D., BPharm (Hons) (@themichaelhe)Photo by Michael He, Ph.D., BPharm (Hons) (@themichaelhe)Photo by Michael He, Ph.D., BPharm (Hons) (@themichaelhe)Photo by Michael He, Ph.D., BPharm (Hons) (@themichaelhe)Photo by Michael He, Ph.D., BPharm (Hons) (@themichaelhe)Photo by Michael He, Ph.D., BPharm (Hons) (@themichaelhe)Photo by Michael He, Ph.D., BPharm (Hons) (@themichaelhe)Photo by Michael He, Ph.D., BPharm (Hons) (@themichaelhe)Photo by Michael He, Ph.D., BPharm (Hons) (@themichaelhe)Photo by Michael He, Ph.D., BPharm (Hons) (@themichaelhe)
Michael He, Ph.D., BPharm (Hons) retweeted
We are looking for a talented postdoctoral bioinformatician ⁦@TheDawsonLab⁩ to work with us on single cell multiomics incorporating lineage tracing and spatial technologies- we specifically want someone curious, fearless with a licence to innovate!! nature.com/naturecareers/job…
1
24
3
66
7,219
Michael He, Ph.D., BPharm (Hons) retweeted
Today in @Nature we share our back-to-back stories with @nzhenguw revealing chemical-genetic convergence between a molecular glue & E3 ligase cancer mutations. 1/6
11
93
9
497
91,968
Michael He, Ph.D., BPharm (Hons) retweeted
UHN is proud to be ranked #1 on the list of Canada’s Top 40 Research Hospitals from @R_Infosource for the 14th year in a row! Thanks to our incredible research community for their continued dedication to #HealthDiscovery, #care & #education! 🔗uhnresearch.ca/news/uhn-isca…
2
19
6
37
9,386
Michael He, Ph.D., BPharm (Hons) retweeted
It takes two to think. Science is a contact sport and one of the reasons why trends in remote work risk scientific progress. Get together - inspire each other.
Doing good science is 90% finding a science buddy to constantly talk to about the project.
1
36
3,141
Michael He, Ph.D., BPharm (Hons) retweeted
Transcriptional/epigenetic chemical inducers of proximity (TCIPs) are an innovative new class of therapeutics that are set to impact lymphoma and other malignancies. Here @RomanSarott, @saigourisankar describe a CDK9 "catch and release" MOA for a new TCIP. science.org/doi/10.1126/scie…
2
16
1,212
Michael He, Ph.D., BPharm (Hons) retweeted
As #BloodCancerAwarenessMonth wraps up, we want to congratulate @PMResearch_UHN’s Dr. Robert Kridel @rkridel for publishing three new studies on #lymphoma. Learn about his team’s dedication to advancing cancer research: 📽️youtu.be/XP0Tnwt2iHY
2
4
6
585
Michael He, Ph.D., BPharm (Hons) retweeted
In vivo CRISPR screen of Epigenetic regulators identity therapeutic targets that rely on tumor microenvironment - our recent work is out at Nature Genetics nature.com/articles/s41588-0… Great teamwork @SoundTsao @DanielSchramek @decarvalho_lab @brooks_lab @kuraoncology and many others
10
24
4
70
8,283
Michael He, Ph.D., BPharm (Hons) retweeted
👏👏 Super kudos to @pmcancercentre @rkridel for this outstanding translational work in follicular #lymphoma. From 713 tumor tissue samples (eg, E4402, E2408 & GALLIUM), 5 genetic subtypes discovered and a/w clinicopath findings & pt outcomes. 👉👉 SEE: rdcu.be/dQmEk
1
13
2
36
4,764
Michael He, Ph.D., BPharm (Hons) retweeted
Our perspective on the synergistic activity of HDAC3i and GNAS silencing in CREBBP wild type B cell lymphoma ⁦⁦⁩ #RobertKridel ⁦@themichaelhe⁩ #PrincessMargaretCancerCenter ⁦@MayoClinic⁩ nature.com/articles/s41375-0…
1
2
18
825
Michael He, Ph.D., BPharm (Hons) retweeted
Our HDAC8 degrader work is now online in JMC! Many thanks to the teams and PIs. Special thanks to colleagues @themichaelhe, Tom Lin& @RashmiKarki12. Stay tuned for more exciting discoveries!
1
1
8
546
Michael He, Ph.D., BPharm (Hons) retweeted
New research led by Professor @MAF_Dawson has found the answer to a decades-long question on cell functioning that could lead to improved #cancer treatments in the future. Find out more 👇petermac.org/about-us/news-a…
1
1
8
1,207
Michael He, Ph.D., BPharm (Hons) retweeted
🚨Attention Postdocs! We're excited to announce the launch of our 2024 UHNPA leadership groups recruitment! 🎉 Open to all UHN postdocs! Want to boost your CV, expand professional network, get priority access to events, or be seen on UHNPA social media? join us now! 🤩
5
8
776
Michael He, Ph.D., BPharm (Hons) retweeted
Researchers in Canada got most of what they were hoping for in the country’s 2024 federal budget, with a big boost in postgraduate pay and more funding for research and scientific infrastructure go.nature.com/4azQ8Ft
9
256
78
1,059
174,009
Michael He, Ph.D., BPharm (Hons) retweeted
**Is single-cell data integration a solved problem? ** Lots of great methods, but still not quite yet! Specifically, Check Dataset Imbalance! 🎉 Excited to announce that our study on dataset imbalances in single-cell analysis just hit Nature Biotechnology (@NatureBiotech)! 🎉 Dive into our paper titled "Characterizing the impacts of dataset imbalance on single-cell data integration" here: nature.com/articles/s41587-0… 🔬 We've thoroughly assessed how dataset imbalances can twist the results of single-cell integration and batch-correction, affecting everything from cell-type classification to differential expression. Our work doesn't just highlight the issue; it offers solid solutions! 🧩 Starting with balanced PBMC data, we uncovered how changing cell-type balance disrupts integration results. But, when we cluster similar cell-types hierarchically, the magic happens – stability is dramatically improved! 📊 We didn't stop there. Our research extends to how these imbalances influence crucial downstream analyses. The impact? Statistically significant changes that could sway biological conclusions. 🛠️ To empower researchers, we've developed a suite of guidelines and introduced innovative balanced clustering metrics. Our tools are designed to navigate the tricky waters of dataset imbalance, ensuring accurate, meaningful results. Check out our full tutorial: github.com/hsmaan/Iniquitate… 🧬 And, for a cherry on top, we've redefined benchmarking standards with new metrics that ensure fair and nuanced interpretation of integration results. Future benchmarking, we've got you covered! Explore our balanced clustering package: github.com/hsmaan/balanced-c… 🔧 Our comprehensive toolkit, including code, data, and detailed documentation, is now fully open-source! We're setting new standards for method development and benchmarking in single-cell integration, with an eye on the broader horizon of representation learning. Get all the goodies here: github.com/hsmaan/Iniquitate Huge congratulations to all the authors, especially the first author, Hassaan Maan, a PhD student I co-supervise with @kieranrcampbell, who almost single-handedly led this project! @UHN @MBPatUofT @VectorInst @UofTCompSci @UofT_LMP @pmcc_ai @UHNAIHUB
15
87
6
403
59,947
Michael He, Ph.D., BPharm (Hons) retweeted
Pre-trained using over 33 million single cell RNA-seq profiles, scGPT is a foundation model facilitating a broad spectrum of downstream single-cell analysis tasks by transfer learning. @BoWang87 @HAOTIANCUI1 @ChloeXWang1 @UofT @VectorInst @UHN nature.com/articles/s41592-0…
48
2
193
26,288
Michael He, Ph.D., BPharm (Hons) retweeted
One of the primary‘products’ of investment in research is talent. We are 500,000 short and falling further behind every year. Canada needs to invest in talent development through research
This Post is from an account that no longer exists. Learn more
1
21
1
60
9,007
Michael He, Ph.D., BPharm (Hons) retweeted
So thrilled to see this wonderful body of work from Vi Wickramasinghe's lab at ⁦@PeterMacRes⁩ along with Greg Goodall ⁦@CCB_Research⁩ - a fundamental discovery with potentially major implications for RNA therapy nature.com/articles/s41586-0…
3
7
2
67
6,462